Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
06/2012
06/26/2012US8207183 Inhibitors of IAP
06/26/2012US8207173 Benzimidazoles and analogs thereof as antivirals
06/26/2012US8207168 Pyridazinone derivatives
06/26/2012US8207158 5HT2c receptor modulators
06/26/2012US8207155 Sulfonyl-azetidin-3-yl-methylamine amide analogs as GlyTl inhibitors, methods for making same, and use of same in treating psychiatric disorders
06/26/2012CA2438582C Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
06/21/2012WO2012083170A1 Anti-viral compounds
06/21/2012WO2012083164A1 Anti-viral compounds
06/21/2012WO2012083112A2 Cyp11b, cyp17, and/or cyp21 inhibitors
06/21/2012WO2012083061A2 Anti-viral compounds
06/21/2012WO2012083059A1 Anti-viral compounds
06/21/2012WO2012083058A2 Anti-viral compounds
06/21/2012WO2012083053A2 Anti-viral compounds
06/21/2012WO2012083043A1 Anti-viral compounds
06/21/2012WO2012082947A1 Compounds and compositions as tgr5 agonists
06/21/2012WO2012082817A1 Biarylamide inhibitors of leukotriene production
06/21/2012WO2012081736A1 Continuous arycyclic compound
06/21/2012WO2012081692A1 Pyrazole derivative
06/21/2012WO2012080447A1 Indoles as respiratory syncytial virus antiviral agents
06/21/2012WO2012080376A1 Insecticidal compounds
06/21/2012WO2012080288A1 4-aminoindole derivatives and use thereof for the oxidation dyeing of keratin fibres
06/21/2012WO2012080286A2 Dyeing composition comprising a heterocyclic oxidation base and a cationic 3,5-diaminopyridine coupler
06/21/2012WO2012080221A1 New compounds for the treatment of neurodegenerative diseases
06/21/2012WO2012079938A1 Method for depigmenting keratin materials using resorcinol derivatives
06/21/2012WO2012051601A3 Heteroarylthio compounds
06/21/2012WO2012044090A3 Novel aminoquinazoline compound having a protein-kinase inhibiting action
06/21/2012WO2012027712A3 Potent and selective inhibitors of hepatitis c virus
06/21/2012WO2012027623A3 Cyanine dyes
06/21/2012WO2011051540A9 Androgen receptor modulating compounds
06/21/2012US20120157681 Luminophores
06/21/2012US20120157680 Ionic liquid containing allylsulfonate anion
06/21/2012US20120157658 Methods, compositions, and apparatuses for forming macrocyclic compounds
06/21/2012US20120157437 Vla-4 inhibitory drug
06/21/2012US20120157432 Novel pyrrolidine derived beta 3 adrenergic receptor agonists
06/21/2012US20120157431 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators
06/21/2012US20120157429 Compounds useful as inhibitors of janus kinases
06/21/2012US20120157427 Pyrazole aminopyrimidine derivatives as lrrk2 modulators
06/21/2012US20120157426 Mutant-selective egfr inhibitors and uses thereof
06/21/2012US20120157412 Substituted Pyrimidinyl Oxime Kinase Inhibitors
06/21/2012US20120157390 IAP Inhibitors
06/21/2012US20120157383 Neprilysin inhibitors
06/21/2012US20120157306 Substituted Fused Pyrimidinones and Dihydropyrimidinones
06/21/2012US20120156311 Combination therapy for cancer comprising a platinum-based antineoplastic agent and a biocompatible electron donor
06/21/2012US20120156219 Nitrogen-containing heterocyclic compounds and medicinal use thereof
06/21/2012CA2822071A1 Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
06/21/2012CA2822000A1 Indoles as respiratory syncytial virus antiviral agents
06/21/2012CA2821973A1 Anti-viral compounds
06/21/2012CA2821900A1 Continuous arycyclic compound
06/21/2012CA2821893A1 Pyrazole derivative
06/21/2012CA2819894A1 Anti-viral compounds
06/21/2012CA2819171A1 New compounds for the treatment of neurodegenerative diseases
06/20/2012EP2465852A1 Capped pyrazinoylguanidine sodium channel blockers
06/20/2012EP2465848A1 Triazolylpiperidine derivatives and method for making the same
06/20/2012EP2465504A1 Novel 2,3-diamino-quinazolinone derivatives and their medical use
06/20/2012EP2464641A1 Pyrimidine compounds as tuberculosis inhibitors
06/20/2012EP2464640A1 Inhibitors of jnk
06/20/2012EP2464631A1 Polycyclic compounds, termed calixurenes, and uses thereof
06/20/2012EP2464231A1 Indazoles as wnt/b-catenin signaling pathway inhibitors and therapeutic uses thereof
06/20/2012EP2464227A1 Compounds and methods of use thereof
06/20/2012EP2227460B1 Therapeutic oxy-phenyl-aryl compounds and their use
06/20/2012EP2203442B1 Substituted pyrrolo-pyrimidine derivatives, process for their preparation and their use as kinase inhibitors
06/20/2012EP2102169B1 Indazolyl amide derivatives for the treatment of glucocorticoid receptor mediated disorders
06/20/2012EP1963276B1 N-linked aryl heteroaryl inhibitors of lta4h for treating inflammation
06/20/2012EP1745041B1 Quinoxaline inhibitors of the hedgehog signalling pathway
06/20/2012CN1906183B N-acylsulfonamide apoptosis promoters
06/20/2012CN102510862A 5-HT3 receptor modulators, methods of making, and use thereof
06/20/2012CN102503896A Methylacryloyl-benzimidazole (sulfur) ketone derivative and application of serving as antibacterial agent thereof
06/20/2012CN102503891A Pyrazole derivatives as 11-beta-hsd1 inhibitors
06/20/2012CN101076528B Organic compound, charge transport material and organic electroluminescent element
06/19/2012USRE43481 Diazepan derivatives or salts thereof
06/19/2012US8203004 Tetrahydroindole derivatives for treatment of alzheimer's disease
06/19/2012US8202924 Polytriazinyl compounds as flame retardants and light stabilizers
06/19/2012US8202876 Compounds and compositions as protein kinase inhibitors
06/19/2012US8202868 4-piperazinyl-pyrimidine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
06/19/2012US8202863 2-Phenyl-pyrimidine-5-carboxylic acid benzylamide; to treat allergic and/or inflammatory disorders, particularly disorders such as allergic rhinitis, asthma and/or chronic obstructive pulmonary disease
06/19/2012US8202861 Compositions useful as inhibitors of voltage-gated sodium channels
06/19/2012CA2684169C Smac mimetic dimers and trimers useful as anti-cancer agents
06/19/2012CA2559302C 6-amino-1h-pyrimidine-2,4-dione derivatives as dipeptidyl peptidase inhibitors
06/19/2012CA2523439C Pyrimidine derivatives useful for the treatment of diseases mediated by crth2
06/19/2012CA2504448C Transcription factor modulating compounds and methods of use thereof
06/14/2012WO2012078777A1 Bicyclic compounds as pim inhibitors
06/14/2012WO2012078005A2 Compounds having hole conducting property, co-adsorbent body comprising same, and dye-sensitized solar cell comprising the co-adsorbent body
06/14/2012WO2012077520A1 Organic electroluminescent element
06/14/2012WO2012076673A1 6-amino-2-phenylamino-1h-benzimidazole-5-carboxamide- derivatives and their use as microsomal prostaglandin e2 synthase-1 inhibitors
06/14/2012WO2012076672A1 2 -aminobenz imidazole derivatives useful in the treatment of inflammation
06/14/2012WO2012076590A1 Novel triazole compounds iii
06/14/2012WO2012076513A1 3-cyano-1-hydroxymethyl-2-phenylpyrrolidine derivatives as inhibitors of mdm2-p53 interactions useful for the treatment of cancer
06/14/2012WO2012076435A1 Pyrimidinone compounds for use in the treatment of diseases or conditions mediated by lp - pla2
06/14/2012US20120149904 Bispyrimidines for electronic applications
06/14/2012US20120149903 Process for preparing and purifying 3-aminopropanol
06/14/2012US20120149710 Sortase a inhibitors
06/14/2012US20120149702 Inhibitors of cellular necrosis
06/14/2012US20120149695 Dihydropyrimidine compounds and preparation methods, pharmaceutical compositions and uses thereof
06/14/2012US20120149687 Heterocyclic compounds and uses thereof
06/14/2012US20120149686 Kinase inhibitors and method of treating cancer with same
06/14/2012US20120149677 Ether benzotriazole derivatives
06/14/2012US20120149676 Novel compounds
06/14/2012US20120149675 1,2,3-triazole-imidazolecompounds
06/14/2012US20120149661 Tetra-substituted heteroaryl compounds and their use as mdm2 and/or mdm4 modulators
06/14/2012US20120149660 Novel n-substituted 5-hydroxypyrollindes as inhibitors of mdm2-p53 interactions
1 ... 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 ... 626